🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Who leaked video from our last Bioworks party?

Matthew E. Kahn To reprise a relevant comment from Don Rubin on this topic: It's easy to signal mathematical aptitude but hard to convey wisdom; we conflate the two, which are not at all the same, even though we care mostly about the latter.

UM V-BID Center told me that my earlier tweet about the 2021 vbid summit vbidcenter.org/2021-virtual-v… would not get as many likes as the tweet by Patrick Conway. He was right. So I try again by tagging Amitabh Chandra, whose twitter reach dwarfs mine

These behind-the-scenes vetoes happen without patient consent: current and future cancer patients (ie, many of us) would not agree this is in our best interest

I don't really know what this means but it sounds cool

Hero work from Margot Sanger-Katz, who combed through the stimulus bill to explain all the new options for health insurance different people will become eligible for. nytimes.com/2021/03/12/ups…

The strong Novavax results in UK - 90% overall effectiveness; 96% w original COVID; 86% w #B117 - indicate we will soon get a 4th vaccine. Amazing. And it adds extra insurance to Biden’s promise to have enough vaccine for all US adults by end of May. novavax.com/sites/default/…

3. In JAMA, Justin Grischkan @AriBFriedman and Amitabh Chandra suggest the best way to fix medical education is to change how it's financed: doi.org/10.1001/jama.2…

A+

“When it comes to something like vaccines, you don’t want the best deal,” he said. “You don’t want to pay the minimum price. You want to overpay and attract the attention of many companies simultaneously.” Amitabh Chandra speaking truth: newyorker.com/science/annals…

"Imagine if AstraZeneca and Merck were the only ones who had taken up the vaccine challenge...We’d be screwed.” Dhruv Khullar dazzles in The New Yorker newyorker.com/science/annals…

FDA should have led J&J #covid19 vaccine decision-making, former commissioner Scott Gottlieb, MD 🇺🇸 writes in The Wall Street Journal. “Putting the is­sue be­fore the CDC con­fused the process and slowed the de­ci­sion.” wsj.com/articles/drug-…

A quick thread on our new Tradeoffs episode out today about the HIV prevention pill PrEP. It’s a story of the best and worst of the US drug system in one drug. 1/ tradeoffs.org/2021/04/22/pre…

I thought health economics deserved its own... let me know what I missed! No shade meant for any of these papers, of course. #healthecon Original source of comic: xkcd.com/2456/

While FDA review is often described as increasing costs and perhaps slowing flow of new products, by certifying quality, this review can grow market size and innovation incentives, from Benjamin Berger, Amitabh Chandra, and @c_garthwaite nber.org/papers/w28889

Millennials have ruined everything, everywhere. cooking.nytimes.com/recipes/102009…

The controversial approval of a new $56,000-a-year #Alzheimers drug against the recommendation of an advisory committee of experts “highlights the importance of having an independent and well-resourced FDA," says Amitabh Chandra. commonwealthmagazine.org/drug-addiction…